Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions Reveals sBLA Submission To FDA To Make BioThrax In Building 55

By: via Benzinga
Emergent Biosolutions Inc (NYSE: EBS) submitted a supplemental Biologics License Application or sBLA to the FDA that sought approval ...
Related Stocks:
Emergent Biosolutions
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.